vectibix

Generic: panitumumab

Labeler: amgen inc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name vectibix
Generic Name panitumumab
Labeler amgen inc
Dosage Form SOLUTION
Routes
INTRAVENOUS
Active Ingredients

panitumumab 100 mg/5mL

Manufacturer
Amgen Inc

Identifiers & Regulatory

Product NDC 55513-954
Product ID 55513-954_9bb2572f-fe38-4675-ae4b-3edc0a437e9d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA125147
Listing Expiration 2026-12-31
Marketing Start 2006-10-10

Pharmacologic Class

Established (EPC)
epidermal growth factor receptor antagonist [epc]
Mechanism of Action
her1 antagonists [moa]
Chemical Structure
antibodies, monoclonal [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55513954
Hyphenated Format 55513-954

Supplemental Identifiers

RxCUI
1657703 1657705 1657722 1657723
UNII
6A901E312A
NUI
N0000175664 N0000020010 M0001357

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name vectibix (source: ndc)
Generic Name panitumumab (source: ndc)
Application Number BLA125147 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 100 mg/5mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (55513-954-01) / 5 mL in 1 VIAL, SINGLE-DOSE
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (55513-954-21) / 5 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (2)

Ingredients (1)

panitumumab (100 mg/5mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "9bb2572f-fe38-4675-ae4b-3edc0a437e9d", "openfda": {"nui": ["N0000175664", "N0000020010", "M0001357"], "unii": ["6A901E312A"], "rxcui": ["1657703", "1657705", "1657722", "1657723"], "spl_set_id": ["e0fa4bca-f245-4d92-ae29-b0c630a315c2"], "pharm_class_cs": ["Antibodies, Monoclonal [CS]"], "pharm_class_epc": ["Epidermal Growth Factor Receptor Antagonist [EPC]"], "pharm_class_moa": ["HER1 Antagonists [MoA]"], "manufacturer_name": ["Amgen Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (55513-954-01)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55513-954-01", "marketing_start_date": "20061010"}, {"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (55513-954-21)  / 5 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "55513-954-21", "marketing_start_date": "20251001"}], "brand_name": "Vectibix", "product_id": "55513-954_9bb2572f-fe38-4675-ae4b-3edc0a437e9d", "dosage_form": "SOLUTION", "pharm_class": ["Antibodies", "Monoclonal [CS]", "Epidermal Growth Factor Receptor Antagonist [EPC]", "HER1 Antagonists [MoA]"], "product_ndc": "55513-954", "generic_name": "panitumumab", "labeler_name": "Amgen Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Vectibix", "active_ingredients": [{"name": "PANITUMUMAB", "strength": "100 mg/5mL"}], "application_number": "BLA125147", "marketing_category": "BLA", "marketing_start_date": "20061010", "listing_expiration_date": "20261231"}